Abstract
Almost all patients with Kawasaki disease take aspirin for 2–3 months after disease onset. During and after such treatment, patients without coronary artery lesions (CAL) are not restricted with respect to sports, vaccination, or normal daily life activities. Management of daily life activities of patients with CAL depends on individual risk of cardiac events, as determined by appropriate assessment techniques. If the patient requires anticoagulant and/or antiplatelet treatment, external injuries should be avoided and participation in contact sports restricted. When warfarin is used, the dose needs to be carefully monitored by blood testing, and the patient should be informed about foods that increase vitamin K levels. Angiograms obtained by computed tomography or magnetic resonance are beginning to supplant catheter angiograms in the morphological evaluation of CAL; however, these modalities have advantages and disadvantages. Echocardiography and scintigraphy with pharmacological or exercise stress testing is useful in functional studies. However, an experienced examiner must be available to conduct and evaluate the results of such tests. As patients age, they must be made aware of the possibility of cardiac sequelae and the need for transition to an adult cardiologist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yamada K, Fukumoto T, Shinkai A, Shirahata A, Meguro T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi. 1978;41(4):791–802. PMID:716791.
Joint Working Group JCS. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014;78(10):2521–62. http://dx.doi.org/10.1253/circj.CJ-66-0096 PMID:25241888.
Sonobe T. Practice of immunization: High-dose gamma-globulin therapy and immunization. Shoni naika. 1994;26:1929–33 (in Japanese).
Miura M, Katada Y, Ishihara J. Time interval of measles vaccination in patients with Kawasaki disease treated with additional intravenous immune globulin. Eur J Pediatr. 2004;163(1):25–9. http://dx.doi.org/10.1007/s00431-003-1335-3 PMID:14624356.
Mason W, Jordan S, Sakai R, Takahashi M. Lack of effect of gamma-globulin infusion on circulating immune complexes in patients with Kawasaki syndrome. Pediatr Infect Dis J. 1988;7(2):94–9. http://dx.doi.org/10.1097/00006454-198802000-00006 PMID:2449651.
Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, Matsumura M, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73(7):1319–23. http://dx.doi.org/10.1253/circj.CJ-08-0931 PMID:19436123.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, American Academy of Pediatrics, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78 PMID:15505111.
Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O’Neill SR, et al. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013;62(12):1114–21. http://dx.doi.org/10.1016/j.jacc.2013.04.090 PMID:23835006.
Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107(5):1095–9. http://dx.doi.org/10.1542/peds.107.5.1095 PMID:11331692.
Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43(1):120–4. http://dx.doi.org/10.1016/j.jacc.2003.08.030 PMID:14715193.
Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997;96(2):454–61. PMID:9244212.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Ayusawa, M. (2017). Long-Term Follow-Up and Education Regarding Daily Life Activities, School Life, and Guidelines After Acute KD. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_33
Download citation
DOI: https://doi.org/10.1007/978-4-431-56039-5_33
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56037-1
Online ISBN: 978-4-431-56039-5
eBook Packages: MedicineMedicine (R0)